Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Don't miss the next one like this
New education grants in US open all the time. Get a free weekly email with only the ones that match — nothing else.
Want help winning this?
Enter your email and we'll send the official application link, deadlines and pointers right away — free. Want a hand? Tick the box and we'll introduce you to a vetted grant or bid writer. The intro's free, and you only pay if you choose to work with them.
- Eligibility
- Open to nonprofit organizations. Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Related opportunities
See all alternatives →SELECTION OF CONSULTANT FIRMS FOR POST-CONTRACT SERVICES FOR THE CONSTRUCTION OF NEW SCHOOLS, UPGRADE AND REHABILITATION OF EXISTING SCHOOLS
→SELECTION OF CONSULTANT FIRMS FOR POST-CONTRACT SERVICES FOR THE CONSTRUCTION OF NEW SCHOOLS, UPGRADE AND REHABILITATION OF EXISTING SCHOOLS
TenderCloses in 10 daysEducationThe selection of Digital Transformation Senior Coordinator
→The selection of Digital Transformation Senior Coordinator
TenderCloses in 9 daysEducationThe Selection of Technical and Vocational Education and Training (TVET) Senior Coordinator
→The Selection of Technical and Vocational Education and Training (TVET) Senior Coordinator
TenderCloses in 9 daysEducationRecruitment of Education and Research Specialist to support the Learning and Evidence Agenda for Regional Collaboration in Eastern and Southern Africa (LEARN-ESA) (P516274)
→Recruitment of Education and Research Specialist to support the Learning and Evidence Agenda for Regional Collaboration in Eastern and Southern Africa (LEARN-ESA) (P516274)
TenderCloses in 8 daysEducationRehabilitation of Shelters (Public Schools) Batch 5: Lot 1 (Jezzine and Chouf), Lot 2 (West Bekaa, Zahle and Rashaya) and Lot 3 (Saida and Hasbaya)
→Rehabilitation of Shelters (Public Schools) Batch 5: Lot 1 (Jezzine and Chouf), Lot 2 (West Bekaa, Zahle and Rashaya) and Lot 3 (Saida and Hasbaya)
TenderCloses in 5 daysEducationNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
→This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research.
Grant$750KCloses 2026-11-13USEducation
People also viewed
Other grants visitors looked at from National Institutes of Health.
IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
→The National Human Genome Research Institute (NHGRI) is publishing a Notice of Funding Opportunity (NOFO) to solicit applications for the Impact of Genomic Variation on Function (IGVF) Data and Coordinating Center (DACC). The DACC will serve as the coordinating center for the IGVF Consortium and will be responsible for expanding and further developing a broadly accessible set of resources, including a data portal and a comprehensive and searchable catalog of measured and predicted variant impacts. The DACC will also seek input on the design of the catalog from the broader research community, organize and facilitate consortium activities, and seek opportunities to work with other programs and consortia. As a member of IGVF, the DACC will work with all consortium members to maximize the consortium's overall scientific impact and contribute to accelerating understanding of genomic variation.
Grant$4MCloses 2026-12-14USHealthSystematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
→The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to characterize genomic variation to assess the impact of individual variants on genome function. This will be accomplished by systematically perturbing variants or elements using one or more high-throughput methods; collecting data on the effects of variants in DNA, RNA, or protein-coding elements on molecular, cellular, or organismal phenotypes; and developing robust, reproducible, and portable data processing pipelines. Centers funded through this initiative will become a part of the Impact of Genomic Variation on Function (IGVF) Consortium. As consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers are also expected to collaborate with other consortium components to coordinate assays, variants, and cell types, and to develop shared analysis strategies to meet consortium goals.
Grant$2MCloses 2026-12-14USHealthGenomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
→The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to study the effects of genetic or environmental interactions on genomic variant impact. To accomplish this, interaction centers will first propose a research framework to investigate whether interactions with effects beyond additive are important modifiers of the impact of variants. Centers will apply their framework to experimentally test combinations for interactions and share their data as well as analyses through the Impact of Genomic Variation on Function (IGVF) portal and catalog. Centers will share their method for predicting the most important combinations for future testing. The rationale for this combination of research and resource work is the identification of a structure within the interaction landscape might result in better predictions of the most important interactions to test, leading to more effective variant testing, better understanding of genome-wide association studies (GWAS), and improved polygenic scores. As IGVF Consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers are also expected to collaborate with other consortium components to coordinate assays, variants, and cell types, and to develop shared analysis strategies to meet consortium goals.
Grant$1.5MCloses 2026-12-14USHealthComputational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
→The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to develop, apply, and test predictive models and perform integrative analyses to determine the impact of genomic variation on genome function. Centers funded through this initiative will become a part of the Impact of Genomic Variation on Function (IGVF) Consortium. As consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers also will collaborate with other consortium components to guide and optimize IGVF experimental design, to provide analytical expertise and support for consortium-wide efforts, and to develop and execute shared analysis strategies to meet consortium goals.
Grant$800KCloses 2026-12-14USHealth
Always confirm details on the official source before applying — see our methodology.